New drug challenges standard for dialysis complication

This study is testing a new drug called MT1013 to see if it works as well or better than the standard medication (cinacalcet) for controlling high parathyroid hormone levels in people on long-term dialysis. About 424 adult patients will be randomly assigned to take either the new drug or the standard one for 26 weeks. Researchers will compare how well each drug lowers hormone levels and manages related bone and mineral problems, while also checking for side effects.